TRACEY TAYLOR: Open Payments
NPI 1437519618 · MILTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,748 in 84 payments from 13 companies in 2025. Trend: 2023 $676 · 2024 $835 · 2025 $1,748
Food & beverage: $1,748
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 22 | $350 |
| AstraZeneca Pharmaceuticals LP | 12 | $308 |
| Insmed, Inc. | 9 | $234 |
| Verona Pharma, Inc. | 10 | $210 |
| Regeneron Healthcare Solutions, Inc. | 8 | $161 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $133 |
| GENZYME CORPORATION | 5 | $106 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Philips North America LLC | 2 | $32 |
Products named: DUPIXENT, Arikayce, AIRSUPRA, Ohtuvayre, NUCALA, TRELEGY ELLIPTA, LUMRYZ, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
